Intuitive Surgical, Inc. (ISRG)
Intuitive Surgical, Inc. (ISRG) Q4 Earnings Surpass Estimates
Intuitive Surgical, Inc. (ISRG) came out with quarterly earnings of $2.53 per share, beating the Zacks Consensus Estimate of $2.25 per share. This compares to earnings of $2.21 per share a year ago.
Intuitive Surgical beats quarterly estimates on demand for surgical robots
Intuitive Surgical on Thursday beat Wall Street estimates for fourth-quarter profit and revenue on growing demand for its surgical robots used in minimally invasive procedures.
ISRG vs. MDT: Which MedTech Stock Is a Better Bet Now?
Intuitive Surgical's pure-play robotics focus, rising da Vinci 5 utilization and 85% recurring revenues tilt the risk-reward versus diversified Medtronic.
Intuitive Surgical Pre-Q4 Analysis: Buy, Hold or Sell ISRG Stock Now?
ISRG heads into Q4 earnings with 18% procedure growth and da Vinci 5 demand, but valuation and tariffs keep the earnings outlook uncertain.
Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results
ISRG posts strong preliminary Q4 and full-year 2025 revenue growth, but shares dip as investors weigh procedure trends, margins and outlook.
Intuitive Surgical: Buying The Dip On This Wide-Moat Compounder
Intuitive Surgical continues robust double-digit growth, with Q4 2025 revenues up 19% y/y and strong da Vinci 5 adoption. The firm's 2026 procedure growth guidance of 13–15% disappointed versus expectations, triggering a recent share sell-off despite operational strength. Elevated multiples reflect the company's market dominance, but tactical buying on dips remains warranted for long-term growth investors.
Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Intuitive Surgical (ISRG) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Get a deeper insight into the potential performance of Intuitive Surgical (ISRG) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Intuitive Surgical, Inc. (ISRG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Intuitive Surgical, Inc. (ISRG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Intuitive Surgical: An Easy 'Buy And Hold' For Long-Term Outperformance
Intuitive Surgical, Inc. dominates surgical robotics with an 80% global share and a robust, recurring-revenue business model anchored by the da Vinci platform. ISRG's installed base and procedure volumes continue double-digit growth, driven by superior clinical outcomes and high hospital switching costs. Despite premium valuation (forward P/E ~64), ISRG's pristine balance sheet, strong margins, and relentless innovation justify a long-term Buy rating.
Intuitive Surgical, Inc. (ISRG) Stock Sinks As Market Gains: Here's Why
The latest trading day saw Intuitive Surgical, Inc. (ISRG) settling at $585.08, representing a -1.21% change from its previous close.
Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock
Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
